| 1. |
- Clausen, Bettina Hjelm, et al.
(författare)
-
Fumarate decreases edema volume and improves functional outcome after experimental stroke
- 2017
-
Ingår i: Experimental Neurology. - : Elsevier BV. - 0014-4886. ; 295, s. 144-154
-
Tidskriftsartikel (refereegranskat)abstract
- Background Oxidative stress and inflammation exacerbate tissue damage in the brain after ischemic stroke. Dimethyl-fumarate (DMF) and its metabolite monomethyl-fumarate (MMF) are known to stimulate anti-oxidant pathways and modulate inflammatory responses. Considering these dual effects of fumarates, we examined the effect of MMF treatment after ischemic stroke in mice. Methods Permanent middle cerebral artery occlusion (pMCAO) was performed using adult, male C57BL/6 mice. Thirty minutes after pMCAO, 20 mg/kg MMF was administered intravenously. Outcomes were evaluated 6, 24 and 48 h after pMCAO. First, we examined whether a bolus of MMF was capable of changing expression of kelch-like erythroid cell-derived protein with CNC homology-associated protein 1 (Keap1) and nuclear factor erythroid 2-related factor (Nrf)2 in the infarcted brain. Next, we studied the effect of MMF on functional recovery. To explore mechanisms potentially influencing functional changes, we examined infarct volumes, edema formation, the expression of heat shock protein (Hsp)72, hydroxycarboxylic acid receptor 2 (Hcar2), and inducible nitric oxide synthase (iNOS) in the infarcted brain using real-time PCR and Western blotting. Concentrations of a panel of pro- and anti-inflammatory cytokines (IFNγ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70, TNF) were examined in both the infarcted brain tissue and plasma samples 6, 24 and 48 h after pMCAO using multiplex electrochemoluminiscence analysis. Results Administration of MMF increased the protein level of Nrf2 6 h after pMCAO, and improved functional outcome at 24 and 48 h after pMCAO. MMF treatment did not influence infarct size, however reduced edema volume at both 24 and 48 h after pMCAO. MMF treatment resulted in increased Hsp72 expression in the brain 6 h after pMCAO. Hcar2 mRNA levels increased significantly 24 h after pMCAO, but were not different between saline- and MMF-treated mice. MMF treatment also increased the level of the anti-inflammatory cytokine IL-10 in the brain and plasma 6 h after pMCAO, and additionally reduced the level of the pro-inflammatory cytokine IL-12p70 in the brain at 24 and 48 h after pMCAO. Conclusions A single intravenous bolus of MMF improved sensory-motor function after ischemic stroke, reduced edema formation, and increased the levels of the neuroprotective protein Hsp72 in the brain. The early increase in IL-10 and reduction in IL-12p70 in the brain combined with changes in systemic cytokine levels may also contribute to the functional recovery after pMCAO.
|
|
| 2. |
- Fex Svenningsen, Åsa, et al.
(författare)
-
Macrophage migration inhibitory factor (MIF) modulates trophic signaling through interaction with serine protease HTRA1
- 2017
-
Ingår i: Cellular and Molecular Life Sciences (CMLS). - : Springer Science and Business Media LLC. - 1420-682X .- 1420-9071. ; 24, s. 4561-4572
-
Tidskriftsartikel (refereegranskat)abstract
- Macrophage migration inhibitory factor (MIF), a small conserved protein, is abundant in the immune- and central nervous system (CNS). MIF has several receptors and binding partners that can modulate its action on a cellular level. It is upregulated in neurodegenerative diseases and cancer although its function is far from clear. Here, we report the finding of a new binding partner to MIF, the serine protease HTRA1. This enzyme cleaves several growth factors, extracellular matrix molecules and is implicated in some of the same diseases as MIF. We show that the function of the binding between MIF and HTRA1 is to inhibit the proteolytic activity of HTRA1, modulating the availability of molecules that can change cell growth and differentiation. MIF is therefore the first endogenous inhibitor ever found for HTRA1. It was found that both molecules were present in astrocytes and that the functional binding has the ability to modulate astrocytic activities important in development and disease of the CNS.
|
|
| 3. |
- Szabó, Tamás, et al.
(författare)
-
Stability and dye inclusion of graphene oxide/polyelectrolyte layer-by-layer self-assembled films in saline, acidic and basic aqueous solutions
- 2017
-
Ingår i: Carbon. - : Elsevier. - 0008-6223 .- 1873-3891. ; 111, s. 350-357
-
Tidskriftsartikel (refereegranskat)abstract
- We demonstrate that a simple spectrophotometric method can be efficiently applied for the characterization of structural and chemical stability and adsorption properties of composite graphene oxide (GO) films in various solutions. The immersion stability of GO layer-by-layer (LbL) self-assembled with a polycation into ultrathin multilayered films was studied in water and in concentrated salty, acidic and basic solutions by UV-visible spectroscopy. These films were found to retain both their chemical stability and physical integrity in water, salt and HCl solutions with a slight rearrangement of the nanoscale structure as shown by the change in their visible spectrum. However, immersion into NaOH solutions above molar concentration led to the deconstruction of the multilayer structure by base-induced deoxygenation of GO. The adsorption of methylene blue on polymer/GO LbL films of various thicknesses revealed that the multilayers are largely impermeable towards this cationic dye.
|
|
